- Home
- VFC vs CORT Comparison
VFC vs CORT Comparison
Compare VFC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VFC | CORT |
|---|---|---|
| Founded | 1899 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VFC | CORT |
|---|---|---|
| Price | $19.48 | $87.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 5 |
| Target Price | $16.13 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 6.0M | 690.9K |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.23 | ★ 0.87 |
| Revenue | ★ $9,541,055,000.00 | $741,172,000.00 |
| Revenue This Year | $0.66 | $23.79 |
| Revenue Next Year | $0.96 | $40.97 |
| P/E Ratio | ★ $84.84 | $100.74 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $9.41 | $49.00 |
| 52 Week High | $29.02 | $117.33 |
Technical Indicators
Market Signals| Indicator | VFC | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 68.05 | 68.66 |
| Support Level | $18.06 | $81.31 |
| Resistance Level | $20.30 | $87.19 |
| Average True Range (ATR) | 0.81 | 2.87 |
| MACD | 0.15 | 0.71 |
| Stochastic Oscillator | 79.27 | 91.96 |
Price Performance
Historical ComparisonAbout VFC V.F. Corporation
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.